(Q39832394)

15 September 2017

In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains (English)

1 reference

15 September 2017

0 references

Smith RP

1

1 reference

15 September 2017

Baltch AL

series ordinal

2

1 reference

15 September 2017

Hammer MC

series ordinal

3

1 reference

15 September 2017

Conroy JV

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 September 1988

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 September 2017

32

1 reference

15 September 2017

9

1 reference

15 September 2017

1450-1455

1 reference

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175890

In vitro activity of CI-934, a quinolone carboxylic acid active against gram-positive and -negative bacteria

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175890

In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175890

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175890

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175890

In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175890

The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175890

Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids

15 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3196008

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro activity of CI-934 and other antimicrobial agents against gram-positive and gram-negative bacteria

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3196008

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.32.9.1450

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

3196008

1 reference